Bejar, R., Lord, A., Stevenson, K., Bar-Natan, M., Pérez-Ladaga, A., Zaneveld, J., . . . Ebert, B. L. (2014). TET2 mutations predict response to hypomethylating agents in myelodysplastic syndrome patients. American Society of Hematology.
Citação norma ChicagoBejar, Rafael, et al. TET2 Mutations Predict Response to Hypomethylating Agents in Myelodysplastic Syndrome Patients. American Society of Hematology, 2014.
Citação norma MLABejar, Rafael, et al. TET2 Mutations Predict Response to Hypomethylating Agents in Myelodysplastic Syndrome Patients. American Society of Hematology, 2014.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.